Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
作者信息
Ehrlich Haley, Elkbuli Adel
机构信息
Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA.
Department of Surgery, Division of Trauma and Surgical Critical Care, Kendall Regional Medical Center, Miami, FL, USA.
出版信息
Am J Emerg Med. 2021 Oct;48:363-364. doi: 10.1016/j.ajem.2021.01.077. Epub 2021 Jan 30.
Abstract
摘要
相似文献
1
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.新型冠状病毒肺炎患者的心律失常：病毒合并症与促心律失常药物相互作用的联合影响
Am J Emerg Med. 2021 Oct;48:363-364. doi: 10.1016/j.ajem.2021.01.077. Epub 2021 Jan 30.
2
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.氯喹、羟氯喹和阿奇霉素对 SARS-CoV-2 感染患者校正 QT 间期的影响。
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29.
3
Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.人类冠状病毒感染相关心律失常的发生率及治疗：系统综述。
Eur J Clin Invest. 2021 Feb;51(2):e13428. doi: 10.1111/eci.13428. Epub 2020 Nov 26.
4
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.在新冠肺炎患者使用羟氯喹和/或阿奇霉素期间控制QT间期以预防尖端扭转型室速
Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.
5
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.一项药物警戒研究定量评估抗疟药物与阿奇霉素联合使用与心律失常之间的关联强度：对 COVID-19 治疗的影响。
Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):159-168. doi: 10.1080/14737167.2021.1851600. Epub 2020 Dec 8.
6
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.COVID-19 药物治疗的心脏安全性：综述及建议监测方案。
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):215-221. doi: 10.1177/2048872620922784. Epub 2020 May 6.
7
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.探索性新冠肺炎治疗中药物相互作用对QTc的影响因素
Circulation. 2020 Jun 16;141(24):e906-e907. doi: 10.1161/CIRCULATIONAHA.120.047521. Epub 2020 Apr 8.
8
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.与阿奇霉素联合或不联合氯喹或羟氯喹相关的QT间期延长或尖端扭转型室速的安全信号。
Res Social Adm Pharm. 2021 Feb;17(2):483-486. doi: 10.1016/j.sapharm.2020.04.016. Epub 2020 Apr 19.
9
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.探索性 COVID-19 治疗中药物相互作用对 QTc 间期的影响因素
J Am Coll Cardiol. 2020 May 26;75(20):2623-2624. doi: 10.1016/j.jacc.2020.04.016. Epub 2020 Apr 10.
10
COVID-19 and Cardiac Concerns for Psychiatric Patients.
Prim Care Companion CNS Disord. 2020 Dec 3;22(6):20com02809. doi: 10.4088/PCC.20com02809.
本文引用的文献
1
COVID-19 infection and cardiac arrhythmias.COVID-19 感染与心律失常。
Trends Cardiovasc Med. 2020 Nov;30(8):451-460. doi: 10.1016/j.tcm.2020.08.002. Epub 2020 Aug 16.
2
Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery.心血管系统参与 2019 冠状病毒病（COVID-19）预后和恢复的关键。
Hellenic J Cardiol. 2020 Nov-Dec;61(6):381-395. doi: 10.1016/j.hjc.2020.05.004. Epub 2020 Jun 10.
3
Cardiovascular manifestations and treatment considerations in COVID-19.新型冠状病毒肺炎的心血管表现和治疗注意事项。
Heart. 2020 Aug;106(15):1132-1141. doi: 10.1136/heartjnl-2020-317056. Epub 2020 Apr 30.
4
Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults.五百万成年人中心律失常的频率。
Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006273. doi: 10.1161/CIRCEP.118.006273.
Zotero 插件